FDA feedback supports 505(b)(2) filing in H2 2026; No additional studies required beyond current planned 32-subject ...

Trump disclosed in a media interview that he took more aspirin than his doctor recommended to stave off cardiac disease.

GLP-1 drugs are 36% more effective than aspirin in reducing colorectal cancer risk, with fewer side effects like acute kidney ...

Aspire does not expect to conduct additional studies beyond its currently planned multicenter crossover clinical trial. ・The ...

Trump takes four times the recommended dose of aspirin for cardiac prevention. Even low-dose aspirin is no longer recommended ...

A number of trials show aspirin is not effective compared with a placebo in primary prevention of stroke, heart attack or ...

Aspirin use in patients with PIK3CA-mutated colorectal cancer reduces recurrence risk by over 50%, found a study published in the Journal of Clinical Oncology. The findings could lead to immediate ...

New studies raise the possibility that GLP-1 medications beat aspirin in reducing colorectal cancer risk, and may improve outcomes for people who do develop the disease.

President Trump told the Wall Street Journal that he has been taking higher doses of aspirin for "cardiac prevention" for ...

Low-dose aspirin may treat flu-induced blood vessel inflammation during pregnancy, thereby improving blood flow to the placenta. The corresponding study was published in Frontiers in Immunology. "This ...

By Dennis Thompson HealthDay ReporterWEDNESDAY, Jan. 7, 2026 (HealthDay News) — Ozempic and Wegovy might help people avoid ...

Your family’s history of cancer suggests a genetic component. Among genetically vulnerable individuals, low-dose aspirin ...